Plan B could make move to OTC status: FDA panel reviews emergency contraceptive.(over the counter): An article from: Internal Medicine News Buy on Amazon
Facebook LinkedIn

Plan B could make move to OTC status: FDA panel reviews emergency contraceptive.(over the counter): An article from: Internal Medicine News

Author Elizabeth Mechcatie
Publisher International Medical News Group
Shop on Amazon — pick your country
🇺🇸 USA 🇨🇦 Canada 🇬🇧 UK 🇩🇪 Germany 🇫🇷 France 🇮🇳 India
5.95 USD
Buy New on Amazon 🇺🇸
Book Details
Author(s) Elizabeth Mechcatie
Publisher International Medical News Group
ISBN / ASIN B0008247XQ
ISBN-13 978B0008247X7
Marketplace United States 🇺🇸
✍️

More Books by Elizabeth Mechcatie

Rx mix-ups prompt Reminyl name change.(Geriatric Psychiatry)(Brief Article): An article from: Clinical Psychiatry News
Rx mix-ups prompt Reminyl name change.(Geriatric Psych…
View
FDA approves extended-release hydromorphone.(pain medicine)(Food and Drug Administration): An article from: Clinical Psychiatry News
FDA approves extended-release hydromorphone.(pain medi…
View
Chronic urticaria.(DRUG UPDATE): An article from: Internal Medicine News
Chronic urticaria.(DRUG UPDATE): An article from: Inte…
View
FDA experts favor OTC sale of plan B: emergency contraception.(over the counter): An article from: Family Practice News
FDA experts favor OTC sale of plan B: emergency contra…
View
Risperidone is approved for Tx of mania in bipolar disorder.(News): An article from: Clinical Psychiatry News
Risperidone is approved for Tx of mania in bipolar dis…
View
FDA to simplify labels of OTC lice treatments: effort to improve success rate.(Rx)(over-the-counter): An article from: Family Practice News
FDA to simplify labels of OTC lice treatments: effort …
View
Olanzapine approved for bipolar maintenance Tx.(Based on 1-year Study): An article from: Internal Medicine News
Olanzapine approved for bipolar maintenance Tx.(Based …
View
FDA launches campaign about OTC drug risks: NSAIDs, acetaminophen.(Rx)(Over The Counter)(Food and Drug Administration)(Nonsteroidal anti-inflammatory agents): An article from: Family Practice News
FDA launches campaign about OTC drug risks: NSAIDs, ac…
View
FDA experts vote in favor of OTC sale of Plan B.(Across Specialties)(Food and Drug Administration)(over the counter): An article from: Clinical Psychiatry News
FDA experts vote in favor of OTC sale of Plan B.(Acros…
View
FDA backs Hylaform as second Hyaluronic filler: no skin test is required prior to injection.(News)(Food and Drug Administration): An article from: Skin & Allergy News
FDA backs Hylaform as second Hyaluronic filler: no ski…
View
Donate to EbookNetworking
← No Prev
No Next →